Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

How to Improve Hair Biopsy Diagnosis: Site Selection, Clinical Information, and Histologic Criteria

Description

The speaker explains how to improve hair biopsy diagnosis by optimizing three factors: the biopsy site, the clinical information provided, and the pathologist’s diagnostic criteria. Using a case where an initial biopsy suggested traction alopecia but later proved to be alopecia areata, the talk shows that incomplete sectioning and limited context can lead to error. For non-scarring alopecia, biopsy should be taken from a thinned but still hairy area rather than the edge of a bald patch; for scarring alopecia, the best site is usually the active advancing border with mild erythema or scale, avoiding scarred or pustular areas. Dermoscopy is emphasized as a tool to choose the best spot, and marked lesions or biopsy-site photos help the pathologist interpret the specimen. The speaker also stresses that minimal clinical history is inadequate, while concise but specific details, the overall pattern of hair loss, and clinical photographs greatly improve interpretation. On the pathology side, he argues for continued education and the use of evidence-based criteria, noting that transverse sections provide rich information about follicle number, size, stage, and inflammation. He concludes that hair loss can be multifactorial, so careful site selection, better clinical data, and robust histologic standards are essential to avoid misdiagnosis and produce more accurate biopsy reports.

View more

Conclusions

  • Biopsy quality in hair loss depends on the combined quality of the clinician, the pathologist, and the tissue specimen.
  • Choosing the right biopsy site is crucial: thinned, active areas for non-scarring alopecia and early, mildly involved advancing borders for cicatricial alopecia.
  • Biopsying too close to the edge of non-scarring alopecia can yield misleadingly normal scalp, while biopsying scarred or highly inflamed areas in cicatricial alopecia often gives nonspecific results.
  • Dermatoscopy helps clinicians place the biopsy punch more precisely and avoid sampling the wrong area.
  • Adequate clinical history, pattern description, and clinical photographs—ideally with the biopsy site marked—substantially improve diagnostic accuracy.
  • Pathologists need additional hair-pathology-specific training and reading beyond routine dermatopathology fellowship to interpret scalp biopsies well.
  • Transverse sectioning of scalp biopsies provides richer diagnostic information than vertical sectioning for many hair disorders.
  • Using the wrong diagnostic criteria can produce confidently wrong diagnoses, so criteria for cicatricial alopecia and multifactorial alopecia should be data-driven.
  • Some patients have more than one cause of hair loss, and recognizing multifactorial alopecia requires careful histologic assessment for overlapping diagnoses.
  • When biopsy site selection, clinical context, and histologic criteria are all optimized, the biopsy report becomes more meaningful, useful, and clinically actionable.
  • Headington JT. Transverse Microscopic Anatomy of the Human Scalp: A Basis for a Morphometric Approach to Disorders of the Hair Follicle. Arch Dermatol. 1984;120:449-456.#10.1001/archderm.1984.01650400031009
  • Wohltmann WE, Sperling LC. Histopathologic diagnosis of multifactorial alopecia. J Cutan Pathol. 2016;43:483-491.#10.1111/cup.12698